Micro Labs Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ABROCITINIB, with a corresponding US DMF Number 41868.
Remarkably, this DMF maintains an Active status since its submission on June 20, 2025, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 24, 2025, and payment made on July 11, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II